Solid Biosciences Inc. (SLDB) Depreciation USD 2017 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Solid Biosciences Inc. quarterly/annual Depreciation history and growth rate from 2017 to 2023.
  • Solid Biosciences Inc. Depreciation for the quarter ending December 31, 2023 was $587 K, a 8.91% increase year-over-year.
  • Solid Biosciences Inc. Depreciation for the twelve months ending December 31, 2023 was $2.58 M, a 7.18% increase year-over-year.
  • Solid Biosciences Inc. annual Depreciation for 2023 was $2.58 M, a 7.18% increase from 2022.
  • Solid Biosciences Inc. annual Depreciation for 2022 was $2.41 M, a 18.8% decline from 2021.
  • Solid Biosciences Inc. annual Depreciation for 2021 was $2.96 M, a 24.4% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $2.58 M $587 K +$48 K +8.91% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $2.53 M $588 K +$150 K +34.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $2.38 M $703 K -$19 K -2.63% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $2.4 M $703 K -$6 K -0.85% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $2.41 M $539 K -$221 K -29.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $2.63 M $438 K -$314 K -41.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $2.94 M $722 K +$4 K +0.56% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $2.94 M $709 K -$25 K -3.41% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $2.96 M $760 K -$36 K -4.52% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-13
Q3 2021 $3 M $752 K -$14 K -1.83% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $3.01 M $718 K -$616 K -46.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $3.63 M $734 K -$292 K -28.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-27
Q4 2020 $3.92 M $796 K -$10 K -1.24% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 $3.93 M $766 K +$2 K +0.26% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $3.93 M $1.33 M +$676 K +103% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $3.25 M $1.03 M +$430 K +72.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $2.82 M $806 K +$325 K +67.6% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-14
Q3 2019 $2.5 M $764 K +$219 K +40.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $2.28 M $658 K +$345 K +110% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $1.94 M $596 K +$369 K +163% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $1.57 M $481 K +$258 K +116% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-15
Q3 2018 $1.31 M $545 K +$435 K +395% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $873 K $313 K +$249 K +389% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $624 K $227 K +$176 K +345% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 $448 K $223 K Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 $110 K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $64 K Mar 30, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 $51 K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.